Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability.

OBJECTIVE To evaluate timing for surgery and management of complex valve lesions in patients with active mitral valve (MV) endocarditis. Results are based on 13 years of experience with MV repair in active endocarditis. METHOD Between 1993 and 2005, 81 patients were operated for active MV endocarditis, of which 63 (or 78%) had MV repair. For all patients, the median time between diagnosis and surgery was 10 days. Diverse surgical techniques were applied to restore MV competence. In 59% of the patients, pericardial patches, tricuspid autograft or partial MV homografts were used as leaflet substitutes. In addition, prosthetic rings were employed in 44% of the patients. RESULTS The overall operative mortality was 17.5%. However, considering only patients in preoperative NYHA class I or II, the operative mortality could be reduced to 4.8%. NYHA class > or =3, elevated age (above 70 years) and history of valvular were the three independent risks factors for early mortality in our multivariate analysis. The average follow-up time was 60+/-37 months. During this period, five late deaths occurred, two of which were cardiac-related. The overall 5- and 10-year survival rate was 73+/-12% and 69+/-13%, respectively. In hospital survivors, freedom from cardiac death after 5 and 10 years was 93+/-8%. Three early and five late MV reoperations occurred in seven patients, of them four could have MV re-repair. Only one endocarditis recurrence occurred after 4 months in a chronic haeamodialysed patient. Freedom from MV reoperation was 89+/-10% and 72+/-24% at 5 and 10 years, respectively. Ten-year freedom from MV replacement and from endocarditis recurrence were 95+/-5% and 98+/-1%, respectively. Annular abscesses and calcified or rheumatic MV disease were two independent risk factors associated with reoperation in our multivariate analysis. During the follow-up period, all patients were in NYHA class I or II; 89% of patients had mitral regurgitation grade < or =I, only 11% had grade II on transthoracic echocardiography. CONCLUSION Using diverse and advanced techniques of MV repair, a reparability rate of 80% can be reached among patients with active endocarditis. We demonstrate that a high level of safety and excellent durability of MV repair can be obtained even for complex repairs.

[1]  A. Berrebi,et al.  Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results in forty-three patients. , 1996, The Journal of thoracic and cardiovascular surgery.

[2]  F. Loop,et al.  Is there an advantage to repairing infected mitral valves? , 1997, The Annals of thoracic surgery.

[3]  C. Mullany,et al.  The advantage of repair of mitral valve in acute endocarditis. , 2002, The Journal of heart valve disease.

[4]  S. Langley,et al.  Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome. , 2000, The Journal of heart valve disease.

[5]  A. Della Corte,et al.  Native versus primary prosthetic valve endocarditis: comparison of clinical features and long-term outcome in 353 patients. , 2004, The Journal of heart valve disease.

[6]  G. El khoury,et al.  Surgical repair of the prolapsing anterior leaflet in degenerative mitral valve disease. , 2000, The Journal of heart valve disease.

[7]  S. Bolling,et al.  Mitral valve reconstruction for active and healed endocarditis. , 1996, Circulation.

[8]  A. Carpentier,et al.  Valve extension with glutaraldehyde-preserved autologous pericardium. Results in mitral valve repair. , 1991, The Journal of thoracic and cardiovascular surgery.

[9]  L. Cohn,et al.  Determinants of early mortality and late survival in mitral valve endocarditis. , 1995, Circulation.

[10]  T. Mihaljevic,et al.  Tailored surgical therapy for acute native mitral valve endocarditis. , 2004, The Journal of heart valve disease.

[11]  C Cabrol,et al.  Active native valve endocarditis: determinants of operative death and late mortality. , 1997, The Annals of thoracic surgery.

[12]  L. Shapiro,et al.  Conservative operation for infective endocarditis of the mitral valve. , 1998, The Annals of thoracic surgery.

[13]  R. S. Mitchell,et al.  Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. , 2001, The Annals of thoracic surgery.

[14]  Gerhard Poelzl,et al.  Mitral valve repair provides improved outcome over replacement in active infective endocarditis. , 2005, The Journal of thoracic and cardiovascular surgery.

[15]  A. Moritz,et al.  Mid-term follow up of mitral valve reconstruction due to active infective endocarditis. , 2000, The Journal of heart valve disease.

[16]  Panos Vardas,et al.  Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. , 2004, European heart journal.

[17]  A. Carpentier,et al.  Long-Term Results of Mitral Valve Repair in Active Endocarditis , 2005, Circulation.

[18]  A. Gillinov,et al.  Current status of mitral valve repair. , 2003, The American heart hospital journal.

[19]  W. Walker,et al.  Predictors of mortality in early surgical intervention for active native valve endocarditis and significance of antimicrobial therapy: a single-center experience. , 2005, The Journal of heart valve disease.

[20]  C. Acar,et al.  Contemporary results of mitral valve repair for infective endocarditis. , 2004, Journal of the American College of Cardiology.

[21]  B. Seifert,et al.  Surgical treatment of infective mitral valve endocarditis. , 2004, The Journal of heart valve disease.

[22]  E. Rosenkranz,et al.  Mitral valve repair for bacterial endocarditis. , 1992, The Journal of thoracic and cardiovascular surgery.

[23]  Sean M. O'Brien,et al.  Surgical treatment of mitral valve endocarditis in North America. , 2005, The Annals of thoracic surgery.

[24]  A. Carpentier,et al.  Valve repair in acute endocarditis. , 1990, The Annals of thoracic surgery.